A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme. https://t.co/zyWnWSOx74

New Research: A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme: Glioblastoma multiforme (GBM) is the most aggressive primary tumor of the central nervous system. As biomedicine advances, the researcher has found… https://t.c

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme https://t.co/d7avNXYNKt